| Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study S Yusuf, S Hawken, S Ôunpuu, T Dans, A Avezum, F Lanas, M McQueen, ... The lancet 364 (9438), 937-952, 2004 | 14905 | 2004 |
| Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study S Yusuf, S Hawken, S Ounpuu, L Bautista, MG Franzosi, P Commerford, ... The Lancet 366 (9497), 1640-1649, 2005 | 3512 | 2005 |
| Association of psychosocial risk factors with risk of acute myocardial infarction in 11 119 cases and 13 648 controls from 52 countries (the INTERHEART study): case-control study A Rosengren, S Hawken, S Ôunpuu, K Sliwa, M Zubaid, WA Almahmeed, ... The Lancet 364 (9438), 953-962, 2004 | 2728 | 2004 |
| Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study KK Teo, S Ounpuu, S Hawken, MR Pandey, V Valentin, D Hunt, R Diaz, ... The lancet 368 (9536), 647-658, 2006 | 1319 | 2006 |
| Lipids, lipoproteins, and apolipoproteins as risk markers of myocardial infarction in 52 countries (the INTERHEART study): a case-control study MJ McQueen, S Hawken, X Wang, S Ounpuu, A Sniderman, J Probstfield, ... The lancet 372 (9634), 224-233, 2008 | 922 | 2008 |
| Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study K Steyn, K Sliwa, S Hawken, P Commerford, C Onen, A Damasceno, ... Circulation 112 (23), 3554-3561, 2005 | 458 | 2005 |
| Oral anticoagulant and antiplatelet therapy and peripheral arterial disease S Anand New England Journal of Medicine 357 (3), 217-227, 2007 | 393 | 2007 |
| Renal function and outcomes in acute coronary syndrome: impact of clopidogrel M Keltai, M Tonelli, JFE Mann, E Sitkei, BS Lewis, S Hawken, SR Mehta, ... European Journal of Preventive Cardiology 14 (2), 312-318, 2007 | 143 | 2007 |
| CFH and ARMS2 genetic polymorphisms predict response to antioxidants and zinc in patients with age-related macular degeneration CC Awh, AM Lane, S Hawken, B Zanke, IK Kim Ophthalmology 120 (11), 2317-2323, 2013 | 138 | 2013 |
| Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study JC Kwong, PP Vasa, MA Campitelli, S Hawken, K Wilson, LC Rosella, ... The Lancet Infectious Diseases 13 (9), 769-776, 2013 | 125 | 2013 |
| Systematic meta-analyses and field synopsis of genetic association studies in colorectal cancer E Theodoratou, Z Montazeri, S Hawken, GCL Allum, J Gong, V Tait, I Kirac, ... Journal of the National Cancer Institute 104 (19), 1433-1457, 2012 | 115 | 2012 |
| Natural history and management of aortocoronary saphenous vein graft aneurysms: a systematic review of published cases FD Ramirez, B Hibbert, T Simard, A Pourdjabbar, KR Wilson, R Hibbert, ... Circulation 126 (18), 2248-2256, 2012 | 113 | 2012 |
| Treatment response to antioxidants and zinc based on CFH and ARMS2 genetic risk allele number in the Age-Related Eye Disease Study CC Awh, S Hawken, BW Zanke Ophthalmology 122 (1), 162-169, 2015 | 100 | 2015 |
| Association between self-reported prenatal cannabis use and maternal, perinatal, and neonatal outcomes DJ Corsi, L Walsh, D Weiss, H Hsu, D El-Chaar, S Hawken, DB Fell, ... Jama 322 (2), 145-152, 2019 | 90 | 2019 |
| Transradial versus transfemoral artery approach for coronary angiography and percutaneous coronary intervention in the extremely obese B Hibbert, T Simard, KR Wilson, S Hawken, GA Wells, FD Ramirez, ... JACC: Cardiovascular Interventions 5 (8), 819-826, 2012 | 87 | 2012 |
| i wsp. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study S Yusuf, S Hawken, S Ounpuu Lancet 364 (9438), 937-952, 2004 | 80 | 2004 |
| Using prospective clinical surveillance to identify adverse events in hospital AJ Forster, JR Worthington, S Hawken, M Bourke, F Rubens, K Shojania, ... BMJ quality & safety 20 (9), 756-763, 2011 | 73 | 2011 |
| External validation of the Hospital-patient One-year Mortality Risk (HOMR) model for predicting death within 1 year after hospital admission C van Walraven, FA McAlister, JA Bakal, S Hawken, J Donzé Cmaj 187 (10), 725-733, 2015 | 56 | 2015 |
| Serum heat shock protein 27 levels represent a potential therapeutic target for atherosclerosis: observations from a human cohort and treatment of female mice TA Seibert, B Hibbert, YX Chen, K Rayner, T Simard, T Hu, CM Cuerrier, ... Journal of the American College of Cardiology 62 (16), 1446-1454, 2013 | 54 | 2013 |
| Effectiveness of a hospital-initiated smoking cessation programme: 2-year health and healthcare outcomes KA Mullen, DG Manuel, SJ Hawken, AL Pipe, D Coyle, LA Hobler, ... Tobacco Control 26 (3), 293-299, 2017 | 51 | 2017 |
Salim YusufPopulation Health Research Institute, McMaster University and Hamilton Health SciencesVerified email at mcmaster.ca
